Reynolds Therapeutics is a pharmaceutical/Medical Device company focused on development of NeuroRelease a novel neurological drug delivery systems for post-operative pain. Founder Frank Reynolds develops targeted delivery systems for drugs, devices, or biologics to treat pain, epilepsy, Parkinson’s disease, and spinal cord injury. Our lead product platform, NeuroRelease™, has achieved sustained therapeutic release of non-opiate drugs for post-operative, acute and chronic pain in pre-clinical models.
View Top Employees from Reynolds Therapeutics| Website | http://www.reynoldstherapeutics.com |
| Ticker | OTCPINK:PXRB |
| Revenue | $32.2 million |
| Funding | $7.8 million |
| Employees | 3 (3 on RocketReach) |
| Founded | 2013 |
| Address | 4250 Steamboat Bend, Fort Myers, Florida 33919, US |
| Phone | (617) 803-8838 |
| Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare, Science and Engineering, Commercial, Drug Manufacturing & Research, Pharmaceutical, Health Care |
| Competitors | ArmaGen, Inc., Sarepta Therapeutics, Strongbridge Biopharma plc, Zocere Inc. Inc |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Reynolds Therapeutics employee's phone or email?
Reynolds Therapeutics Questions
The Reynolds Therapeutics annual revenue was $32.2 million in 2024.
3 people are employed at Reynolds Therapeutics.
Reynolds Therapeutics is based in Fort Myers, Florida.
The NAICS codes for Reynolds Therapeutics are [3254, 32, 32541, 325].
The SIC codes for Reynolds Therapeutics are [283, 28, 2834].
Top Reynolds Therapeutics Employees
-
View
Frank Reynolds
CEO, CFO, CSO, and Founder Reynolds Therapeutics at Reynolds Therapeutics
North Las Vegas, Nevada, United States25+ -
25+
Related Companies
